Navigation Links
Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection
Date:2/6/2012

SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today the voluntary recall of a single lot of OFIRMEV® (acetaminophen) injection. Cadence has notified the U.S. Food and Drug Administration of the recall.

The recall of OFIRMEV lot number V005710 was initiated due to the presence of an unidentified, visible particle in one vial of this lot during routine stability testing.  Lot V005710 was distributed by Cadence to hospitals, wholesalers and distributors beginning in January 2011, and Cadence believes that fewer than 1,000 vials currently remain in the marketplace. Cadence has not received any reports of adverse patient events associated with particulate matter in the product, and has undertaken the recall as a precautionary measure.  

"We regret that some of our customers experienced short-term supply delays due to our temporary suspension of shipments from the supplier of lot V005710," said Scott Byrd, Chief Commercial Officer of Cadence. "Fortunately, we were successful in our efforts to accelerate shipments of OFIRMEV from another supplier, which allowed us to quickly resume normal shipments of the product. We do not anticipate any further supply delays."

Customer Recall ContactCustomers with questions regarding this recall should call 1-866-338-4070.About OFIRMEV® (Acetaminophen) InjectionOFIRMEV (acetaminophen) injection (1000 mg / 100 mL, 10 mg / mL; for intravenous use only), Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. The FDA approval of
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
2. Cadence Pharmaceuticals Announces Completion of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters
3. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2011 Financial Results on November 3, 2011
6. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
7. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
8. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
9. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
10. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
11. Cadence, Inc. Announces Major Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World ... aligned with the latest trends and events, companies ... can predict where an industry is headed next, ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... with market research publisher GlobalData, offer decision makers ...
(Date:5/22/2013)... N.Y. , May 22, 2013  The Leukemia ... million to Valor Biotherapeutics, LLC, a joint venture ... pre-clinical development, manufacturing, and a Phase I clinical trial ... poor outcomes faced by many patients with indolent lymphomas ... Valor,s protein, IGN002, is a new ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Is There Finally A Way To Stop Severe Excessive Sweating? 2
... LOCI(R) chemiluminescence ... technology, ... it has launched the LOCI(R) Folate,LOCI(R) B12, and LOCI(R) Ferritin tests ... chemistry analyzer. These,tests are used by physicians to diagnose and monitor ...
... accepted for filing the New, Drug Application (NDA) for ... adjunctive treatment of partial onset seizures in adults ... today that the New Drug,Application (NDA) for the use ... treatment of partial onset seizures in,adults with epilepsy has ...
Cached Medicine Technology:Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System 2Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System 3Keppra XR(TM) Extended-Release Tablets Filed with the FDA 2Keppra XR(TM) Extended-Release Tablets Filed with the FDA 3Keppra XR(TM) Extended-Release Tablets Filed with the FDA 4
(Date:5/23/2013)... New techniques in imaging of brain activity developed ... Neurological Institute, and his colleagues lead to improved ... combination of electroencephalogram (EEG) and functional magnetic resonance ... the areas generating epileptic seizures, giving neurosurgeons a ... if appropriate. These results were presented at ...
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 According to ... [Converged Services; Policy Management; Subscriber Data Management (SDM); Telecom ... Forecasts and Analysis (2013 – 2018)", published by MarketsandMarkets, ... by 2018 at a CAGR of 9.15% from 2013 ... Market Data Tables , 84 Figures , ...
(Date:5/23/2013)... Located at 22343 La Palma Ave. #125, fitness ... Grand Opening Family Fun Charity event on May 11, 2013 ... physical fitness. Sponsored by many different vendors like Chick-fil-a and ... Grand Opening featured mini boot camp sessions and raffled off ... Yorba Linda fitness center has to offer. ...
(Date:5/23/2013)... In Florida, residents have not been hit ... however, that Florida’s good luck will continue, warns Rick Knabb, ... he encourages residents, it is important to prepare as if ... predicting there to be a 50-percent chance that a major ... season lasting from June 1 to November 30 in Florida, ...
Breaking Medicine News(10 mins):Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... America,s Future co-director Roger Hickey , Economic Policy ... Economic and Policy Research co-director Dean Baker ... President Obama ,s summit today on the nation,s future ... LAWRENCE MISHEL We applaud President ...
... Feb. 23 The non-profit LENA(TM) Foundation, which develops ... language disorders, has released two case studies showing how ... autism treatment. The LENA software enables the clinician ... turns at 5-minute and hourly intervals over the course ...
... eFoodSafety.com, Inc., (OTC Bulletin Board: EFSF) an emerging ... dermatology, environmental and nutraceutical products, today announced that Martin ... future Chairman and CEO of eFoodSafety.com, has purchased stock ... total of 100,000 shares in the open market on ...
... in Phoenix to Focus on Catheter Reduction and ... SEGUNDO, Calif., Feb 23 DaVita Inc., a ... 2009 Clinical Priorities to its partnering nephrologists during ... of the largest gatherings of nephrologists of the ...
... Practices provide guidance for healthcare systems in ... and community engagementWASHINGTON, Feb. 23 The ... to improving healthcare quality, has endorsed 45 ... care that is culturally appropriate and patient-centered. ...
... 23 Vanda Pharmaceuticals Inc. (Nasdaq: ... statement regarding two letters sent to Vanda by Tang Capital ... its intent to, among other things, nominate two directors to ... and submit proposals at the 2009 Annual Meeting to amend ...
Cached Medicine News:Health News:Progressive Leaders at White House Summit Today Underscore Need for Health Care Reform 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 3Health News:eFoodSafety.com Announces Open Market Stock Purchase by Management 2Health News:DaVita Releases Top Clinical Priorities for 2009 2Health News:DaVita Releases Top Clinical Priorities for 2009 3Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 2Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 2Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 4Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 5Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 6
... The Stereo Cube is used to diagnose ... without the use of polarized glasses. The ... of binocularity, stereopsis, visual attention, form and depth ... of 850 to 450 seconds of arc and ...
... created to simplify stereopsis screening in children. It ... cylindrical gratings. Lang Stereotest II measures disparities: Moon ... 600 seconds of arc plus monocularly visible star. ... dots are smaller and less dense. This disparity ...
... provide accurate measurement of stereopsis. These ... polarized glasses. The original comes with ... a thin plastic frame with plastic ... new P/N 4465 Polycarbonate polarized hard ...
... stereo test was developed to test for both ... employs the more reliable red/green glasses to ... not dependent on polarizing spectacles which can be ... an attractive image of a butterfly which makes ...
Medicine Products: